| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |